Curtiss-Wright Delivers Record FY25 Financials, Forecasts Strong 2026 Growth
CW has more than doubled off its 52-week low of $266.879.
Summary
Curtiss-Wright reported record full-year 2025 financial results, including double-digit adjusted EPS growth, and issued strong 2026 guidance projecting continued sales and EPS expansion.
Key Events · Earnings and Guidance · CW
-
Record Full-Year 2025 Performance
Achieved record adjusted sales of $3.5 billion (up 12%), adjusted operating income of $651 million (up 19%), and adjusted diluted EPS of $13.23 (up 21%).
-
Strong Fourth Quarter 2025 Results
Reported adjusted sales of $947 million (up 15%) and adjusted diluted EPS of $3.79 (up 16%), with a robust book-to-bill ratio of 1.2x.
-
Positive Full-Year 2026 Guidance
Forecasts 6-8% sales growth, 8-11% operating income growth, and 11-15% diluted EPS growth, with operating margin expansion of 30-60 basis points.
-
Significant Share Repurchases
Repurchased $465 million in shares during full-year 2025 and plans a minimum of $60 million in repurchases for 2026 to offset dilution.
Analysis · CW · Technology
Curtiss-Wright Corporation reported record financial results for the full year 2025, demonstrating significant momentum from its 'Pivot to Growth' strategy. The company achieved record sales, profitability, EPS, free cash flow, and new orders, with adjusted diluted EPS growing 21%. The strong performance was driven by robust demand across Aerospace & Defense and Commercial Nuclear markets. Furthermore, the company provided an optimistic outlook for 2026, projecting continued sales growth of 6-8%, operating margin expansion, and double-digit diluted EPS growth of 11-15%. This positive news, released while the stock is trading near its 52-week high, reinforces investor confidence in the company's strategic direction and operational execution. The substantial backlog of $4.1 billion further underpins the projected future growth.
At the time of this filing, CW was trading at $676.30 on NYSE in the Technology sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $266.88 to $683.09. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.